These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 16439532

  • 1. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A.
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [Abstract] [Full Text] [Related]

  • 2. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.
    Agnello D, Hervé CA, Lavaux A, Darniot M, Guillon P, Charpilienne A, Pothier P.
    J Virol; 2006 Apr; 80(8):3823-32. PubMed ID: 16571799
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M, Cai L.
    Viral Immunol; 2001 Apr; 14(1):31-47. PubMed ID: 11270595
    [Abstract] [Full Text] [Related]

  • 5. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH, Basu M, Rae MN, McNeal MM, Ward RL.
    Virology; 1998 Oct 10; 250(1):230-40. PubMed ID: 9770437
    [Abstract] [Full Text] [Related]

  • 6. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
    Shuttleworth G, Eckery DC, Awram P.
    Arch Virol; 2005 Feb 10; 150(2):341-9. PubMed ID: 15578236
    [Abstract] [Full Text] [Related]

  • 7. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
    Yuan L, Azevedo MS, Gonzalez AM, Jeong KI, Van Nguyen T, Lewis P, Iosef C, Herrmann JE, Saif LJ.
    Vaccine; 2005 Jun 10; 23(30):3925-36. PubMed ID: 15917114
    [Abstract] [Full Text] [Related]

  • 8. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
    Ogier A, Franco MA, Charpilienne A, Cohen J, Pothier P, Kohli E.
    Eur J Immunol; 2005 Jul 10; 35(7):2122-30. PubMed ID: 15948217
    [Abstract] [Full Text] [Related]

  • 9. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
    Revaz V, Zurbriggen R, Moser C, Schiller JT, Ponci F, Bobst M, Nardelli-Haefliger D.
    Antiviral Res; 2007 Oct 10; 76(1):75-85. PubMed ID: 17617476
    [Abstract] [Full Text] [Related]

  • 10. Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice.
    Istrate C, Hinkula J, Charpilienne A, Poncet D, Cohen J, Svensson L, Johansen K.
    Vaccine; 2008 Aug 18; 26(35):4594-601. PubMed ID: 18588935
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of a Bacillus subtilis-based rotavirus vaccine.
    Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, Keusch GT, Tzipori S, Sonenshein AL, Herrmann JE.
    Clin Vaccine Immunol; 2010 Nov 18; 17(11):1647-55. PubMed ID: 20810679
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O, Gutierrez-Xicotencatl L, Plett-Torres T, Pedroza-Saavedra A, Gonzalez-Jaimes A, Chihu-Amparan L, Maldonado-Gama M, Espino-Solis G, Bonifaz LC, Esquivel-Guadarrama F.
    Vaccine; 2015 Aug 20; 33(35):4228-37. PubMed ID: 25850020
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J, Schmitz N, Hinton HJ, Schwarz K, Jegerlehner A, Bachmann MF.
    Eur J Immunol; 2008 Jan 20; 38(1):114-26. PubMed ID: 18081037
    [Abstract] [Full Text] [Related]

  • 20. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
    Liu X, Yang T, Sun QM, Sun MS.
    Acta Virol; 2005 Jan 20; 49(1):17-22. PubMed ID: 15929394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.